The hidden value of MRI: modifying treatment decisions in C-spine injuries.

Background Data: Computed Tomography (CT) is the gold standard for cervical spine (c-spine) evaluation. Magnetic resonance imaging (MRI) emerges due to its increasing availability and the lack of radiation exposure. However, MRI is costly and time-consuming, questioning its role in the emergency department (ED).

Imaging local diffusion in microstructures using NV-based pulsed field gradient NMR.

Understanding diffusion in microstructures plays a crucial role in many scientific fields, including neuroscience, medicine, or energy research. While magnetic resonance (MR) methods are the gold standard for diffusion measurements, spatial encoding in MR imaging has limitations. Here, we introduce nitrogen-vacancy (NV) center-based nuclear MR (NMR) spectroscopy as a powerful tool to probe diffusion within microscopic sample volumes.

Optimal bi-planar gradient coil configurations for diamond nitrogen-vacancy based diffusion-weighted NMR experiments.

Introduction: Diffusion weighting in optically detected magnetic resonance experiments involving diamond nitrogen-vacancy (NV) centers can provide valuable microstructural information. Bi-planar gradient coils employed for diffusion weighting afford excellent spatial access, essential for integrating the NV-NMR components. Nevertheless, owing to the polar tilt of roughly [Formula: see text] of the diamond NV center, the primary magnetic field direction must be taken into account accordingly.

Cervical spine trauma - Evaluating the diagnostic power of CT, MRI, X-Ray and LODOX.

Background: Traumatic cervical spine (c-spine) injuries account for 10% of all spinal injuries. The c-spine is prone to injury by blunt acceleration/deceleration traumas. The Canadian C-Spine rule and NEXUS criteria guide clinical decision-making but lack consensus on imaging modality when necessary.

Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia.

Purpose: Isocitrate dehydrogenase 1 (IDH1) mutations occur in 5% to 10% of patients with acute myeloid leukemia (AML). Ivosidenib is an IDH1 inhibitor, approved for use in patients with IDH1-mutated AML.

Patients And Methods: We conducted a multicenter, phase I trial of maintenance ivosidenib following allogeneic hematopoietic cell transplantation (HCT) in patients with IDH1-mutated AML.